Neurology & Psychiatry Clinical Trial Services

The Challenge is the Opportunity

Over the past decade, the likelihood of approval in neuropsychiatry indications is barely 6%. And with nearly a quarter of all Americans having at least one CNS disorder and the majority of effective treatments dating back to the 1950s, the need for better solutions is clear. The way we see it, past failure isn’t a problem – it’s an opportunity.

Expertise in Action

• Outstanding track record starting up and executing CNS trials
  Excellent site relationships that will help meet your enrollment goals
  Expertise managing and distributing Schedule II drugs
  Experience at FDA meetings handling missing data problems